Kiniksa Pharmaceuticals International, plc

IPO

Kiniksa Pharmaceuticals | A Global and Innovative Biopharmaceutical Company

Public · Lexington, United States · $80.0M raised

Business Model
B2C
Total Funding
$80.0M
Last Round
$80.0M Series BMar 2017
Rounds
2
Type
Public

About

Global biopharmaceutical company delivering novel treatments for patients with serious unmet medical needs.

Summary

Kiniksa Pharmaceuticals International, plc is a Biotech company based in Lexington, United States. It has raised $80.0M in total across 2 rounds, most recently a $80.0M Series B round in Mar 2017. Investors include Sofinnova Investments.

Tech & App Stack

5 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Funding History

IPOMay 2018
$152.6M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies